Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate on Cardiovascular Mortality and Morbidity in Patients With Chronic Kidney Disease on Hemodialysis (CKD5D)
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2019
Price : $35 *
At a glance
- Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
- Indications Hyperphosphataemia
- Focus Adverse reactions
- Acronyms LANDMARK
- 26 Mar 2019 Status changed from active, no longer recruiting to completed.
- 06 Dec 2018 Planned End Date changed from 1 Feb 2019 to 26 Jun 2018.
- 13 Sep 2018 Planned End Date changed from 31 Jul 2018 to 1 Feb 2019.